When: Successful $200 SMA retest at $333 with bullish reversal candle (engulfing or hammer) + >30M volume + MACD histogram turning positive

Then: Add toward 7% weight

When: Pullback to $314-320 zone with confirmed momentum recovery (RSI turning back up, MACD histogram positive for 3 sessions)

Then: Add toward full 7%+ weight

HOLD at 5% allocation; do not increase exposure until confirmation at 314-320 support or 350 breakout

• Current price at $339.35 provides only ~$5 cushion above 200 SMA at $334, which is less than one day of normal volatility (ATR $8.37)
• Cash position of $242 billion is offset by debt up 217% YoY, $30B net equity issued last quarter, $18B preferred issued, and $33B Wiz acquisition as goodwill
• Free cash flow deteriorated from +$5.3B to -$5.9B in one year; forward EPS $14.83 vs trailing $19.93
• All short-term momentum indicators bearish: price below 10 EMA and 50 SMA, MACD at -0.26, RSI sub-50, VWMA above price
• OpenAI ads at $1B annualized run rate with 10x acceleration in 4 months is an emerging competitive threat, not a rounding error
• Position size of 5% is appropriate given 1.24 beta, September seasonality, 88% no-cut Fed odds, and geopolitical oil above $90
• Trim trigger at 334 (200 SMA daily close on volume) is correctly calibrated to the level that defines long-term trend integrity
• Scale-in zones at 314-320 or above 350 with volume are higher-probability entries than DCAing into a confirmed downtrend
• Higher-for-longer rates compress long-duration growth multiples; 32x normalized P/E has further to compress if rates stay sticky

→ vs aggressive: Calling a $5 cushion above the 200 SMA with an ATR of $8.37 a 'clearance sale' reads the chart you want, not the chart in front of you; every momentum indicator is aligned bearish short-term

→ vs aggressive: The 'fortress balance sheet' ignores $242B cash is being deployed as ammo (debt +217% YoY, $30B equity issued, $18B preferred, $33B Wiz acquisition) not armor; FCF went from +$5.3B to -$5.9B

→ vs aggressive: AI capex extending into 2027 means more negative FCF, more debt, more dilution, and impaired assets if monetization disappoints; capex is the largest risk variable, not a tailwind

→ vs aggressive: OpenAI ads threat dismissed too quickly; $1B run rate with 10x acceleration is a trend, not noise; market's 2.7% reaction was an early read on a multi-year margin compression story

→ vs aggressive: 7-8% position size into September (weakest month), 88% no-cut odds, oil above $90, bearish chart, and fresh competitive narrative is concentration risk masquerading as conviction

→ vs aggressive: Scale-in between 320-345 is DCAing into a downtrend without confirmation; tranches become averaging down if 334 breaks; wait for reversal above 350 or tested 314-320 support

→ vs aggressive: Framing 88% no-cut odds as 'discipline' rather than a headwind is a narrative trick; higher-for-longer rates work the term structure of valuation and compress growth multiples

HOLD at 5% core position. Do not add at 339, do not trim from current level. Set decision points: above 350 on volume above 50 million shares upgrade to buy and consider scaling toward 6%; below 334 on daily close with volume downgrade to trim to 4% and reassess; second close below 328 with no momentum recovery triggers further reduction. 314-320 zone remains higher conviction re-entry if reached with improving momentum, where willing to deploy up to 7%.

• Stock below 10 EMA, below 50 SMA, MACD negative, RSI in lower half, VWMA above price - trend of force is down but histogram narrowing is encouraging
• MACD histogram narrowing is deceleration in selling, not confirmation of inflection - narrowing isn't crossing
• July 23rd capitulation candle on 69 million shares held the 315 zone - successful test of major support level
• Stock is resting on critical long-term level after 10% drawdown from highs, not coiled at highs about to collapse
• OpenAI monetization infrastructure at scale demonstrated for first time - 10x growth in four months is acceleration that could be meaningful over 3-5 year window
• Cash position grew 155% to $242 billion, current ratio 2.72, TTM operating cash flow $186 billion - funding AI capex from extraordinary liquidity not leverage
• Debt up 217% but context matters given cash position growth
• Forward P/E stable at 22-23x - market correctly discounting near-term earnings drag without expecting structural impairment
• If market expected structural impairment, would see multiple compression to 18-20x, not stable at 22-23x
• GOOGL at 1.24 beta into worst seasonal month with elevated macro uncertainty is not moment for increased single-name concentration
• 5% cap preserves long-term thesis exposure while keeping portfolio flexibility intact
• Mixed macro (88% no-cuts pricing weighs on multiples but soft landing absence of recession is supportive) means single-name decisions should lean on company-specific factors and technical confirmation

→ vs aggressive: MACD histogram narrowing is deceleration in selling, not inflection confirmation - interpreting it as such risks adding capital at progressively worse prices into confirmed structural break if 334 gives way on volume

→ vs aggressive: OpenAI threat is not headline to wave away - anchoring on absolute size ($1B vs hundreds of billions) while ignoring slope of curve (10x in four months) is the same mistake the market makes in reverse

→ vs aggressive: 7-8% allocation is concentration risk dressed up as conviction - with 1.24 beta, worst seasonal month, elevated macro uncertainty, and unresolved chart, not moment to increase idiosyncratic risk

→ vs conservative: Treating every indicator as confirmation of bearishness when some show genuine stabilization - MACD histogram narrowing is first hint of downside momentum exhausting, not bearish

→ vs conservative: Ignoring 25 dollar cushion below August high while focusing only on 5 dollar cushion above 200 SMA - stock has already absorbed meaningful pullback

→ vs conservative: Overstating capex risk - management is voluntarily deploying capital from position of extraordinary liquidity, not being forced to by leverage - strategic choice with risk, not defensive move out of weakness

→ vs conservative: Forward EPS revision cited as evidence market pricing in trouble reads as market correctly discounting near-term earnings drag while keeping long-term valuation framework intact

→ vs conservative: Trim case premature when long-term structure intact and 315 support level hasn't broken - don't capitulate to fear when data hasn't justified it